These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9816043)
21. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Ahrendt SA; Chow JT; Yang SC; Wu L; Zhang MJ; Jen J; Sidransky D Cancer Res; 2000 Jun; 60(12):3155-9. PubMed ID: 10866304 [TBL] [Abstract][Full Text] [Related]
22. Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. Lohmann D; Pütz B; Reich U; Böhm J; Präuer H; Höfler H Am J Pathol; 1993 Mar; 142(3):907-15. PubMed ID: 8384408 [TBL] [Abstract][Full Text] [Related]
23. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients. Gao W; Mady HH; Melhem MF; Keohavong P Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763 [TBL] [Abstract][Full Text] [Related]
24. Gender differences in p53 mutational status in small cell lung cancer. Tseng JE; Rodriguez M; Ro J; Liu D; Hong WK; Mao L Cancer Res; 1999 Nov; 59(22):5666-70. PubMed ID: 10582680 [TBL] [Abstract][Full Text] [Related]
25. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers. Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671 [TBL] [Abstract][Full Text] [Related]
27. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Tomizawa Y; Kohno T; Fujita T; Kiyama M; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Nakajima T; Yokota J Oncogene; 1999 Jan; 18(4):1007-14. PubMed ID: 10023676 [TBL] [Abstract][Full Text] [Related]
28. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Skaug V; Ryberg D; Kure EH; Arab MO; Stangeland L; Myking AO; Haugen A Clin Cancer Res; 2000 Mar; 6(3):1031-7. PubMed ID: 10741731 [TBL] [Abstract][Full Text] [Related]
29. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767 [TBL] [Abstract][Full Text] [Related]
30. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567 [TBL] [Abstract][Full Text] [Related]
31. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551 [TBL] [Abstract][Full Text] [Related]
32. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962 [TBL] [Abstract][Full Text] [Related]
33. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Hu Y; McDermott MP; Ahrendt SA Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626 [TBL] [Abstract][Full Text] [Related]
34. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590 [TBL] [Abstract][Full Text] [Related]
35. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030 [TBL] [Abstract][Full Text] [Related]
36. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Ryberg D; Kure E; Lystad S; Skaug V; Stangeland L; Mercy I; Børresen AL; Haugen A Cancer Res; 1994 Mar; 54(6):1551-5. PubMed ID: 8137262 [TBL] [Abstract][Full Text] [Related]
37. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037 [TBL] [Abstract][Full Text] [Related]
38. The TP53 gene, tobacco exposure, and lung cancer. Toyooka S; Tsuda T; Gazdar AF Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108 [TBL] [Abstract][Full Text] [Related]
39. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438 [TBL] [Abstract][Full Text] [Related]
40. Evidence for common clonal origin of multifocal lung cancers. Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]